Natori S, Karashima T, Koga S, Abe M, Tominaga K
Department of Internal Medicine, Iizuka Hospital.
Fukuoka Igaku Zasshi. 1991 Aug;82(8):461-3.
A 37-year old housewife was admitted to our department because of long-standing amenorrhoea and galactorrhoea. After several hormonal examinations, she was proved to be suffered from primary hypothyroidism with hyperprolactinemia. In addition, brain computed tomography (CT) showed the finding of enhanced pituitary enlargement, suggesting pituitary hypertrophy or pituitary adenoma. Based on some therapeutic experiences in similar cases in several reports, we have performed only thyroid hormone replacement and followed up the patient. Plasma thyroid stimulating hormone (TSH) and prolactin concentrations returned to normal range in a few months after starting thyroid hormone replacement. Furthermore, the finding of pituitary enlargement has completely disappeared on brain CT and come to pregnancy during the course. Thus, it seems that the finding of pituitary enlargement might be due to pituitary hypertrophy. Therefore, we think that thyroid hormone replacement should be a first choice therapy preceding the pituitary surgery or bromocriptine therapy in such a case.
一名37岁的家庭主妇因长期闭经和溢乳入住我科。经过多项激素检查,证实她患有原发性甲状腺功能减退症伴高泌乳素血症。此外,脑部计算机断层扫描(CT)显示垂体增大并有强化表现,提示垂体肥大或垂体腺瘤。根据几份报告中类似病例的一些治疗经验,我们仅对患者进行了甲状腺激素替代治疗并进行随访。开始甲状腺激素替代治疗后的几个月内,血浆促甲状腺激素(TSH)和泌乳素浓度恢复到正常范围。此外,脑部CT显示垂体增大的表现已完全消失,并且在此期间患者怀孕。因此,垂体增大似乎可能是由于垂体肥大所致。所以,我们认为在这种情况下,甲状腺激素替代治疗应作为垂体手术或溴隐亭治疗之前的首选治疗方法。